# Mirasol-Treated Platelets - (Pathogen Reduction Extended Storage Study)

> **NCT01368211** · PHASE2,PHASE3 · TERMINATED · sponsor: **Terumo BCTbio** · enrollment: 16 (actual)

## Conditions studied

- Thrombocytopenia

## Interventions

- **BIOLOGICAL:** 2-4-day-old Mirasol-treated Platelets Transfusion
- **BIOLOGICAL:** 2-4-day-old Untreated Platelets Transfusion

## Key facts

- **NCT ID:** NCT01368211
- **Lead sponsor:** Terumo BCTbio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-09
- **Primary completion:** 2011-04
- **Final completion:** 2011-05
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** Part 1 completed, part 2 not done due to slow enrollment
- **Last updated:** 2016-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01368211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01368211, "Mirasol-Treated Platelets - (Pathogen Reduction Extended Storage Study)". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01368211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*